Literature DB >> 16774856

Microarray analysis on Runx2-deficient mouse embryos reveals novel Runx2 functions and target genes during intramembranous and endochondral bone formation.

Bart L T Vaes1, Patricia Ducy, Anneke M Sijbers, José M A Hendriks, Eugene P van Someren, Nanning G de Jong, Edwin R van den Heuvel, Wiebe Olijve, Everardus J J van Zoelen, Koen J Dechering.   

Abstract

A major challenge in developmental biology is to correlate genome-wide gene expression modulations with developmental processes in vivo. In this study, we analyzed the role of Runx2 during intramembranous and endochondral bone development, by comparing gene expression profiles in 14.5 dpc wild-type and Runx2 (-/-) mice. A total of 1277, 606 and 492 transcripts were found to be significantly modulated by Runx2 in calvaria, forelimbs and hindlimbs, respectively. Bioinformatics analysis indicated that Runx2 not only controls the processes of osteoblast differentiation and chondrocyte maturation, but may also play a role in axon formation and hematopoietic cell commitment during bone development. A total of 41 genes are affected by the Runx2 deletion in both intramembranous and endochondral bone, indicating common pathways between these two developmental modes of bone formation. In addition, we identified genes that are specifically involved in endochondral ossification. In conclusion, our data show that a comparative genome-wide expression analysis of wild-type and mutant mouse models allows the examination of mutant phenotypes in complex tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16774856     DOI: 10.1016/j.bone.2006.04.024

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  15 in total

1.  Dose-dependent effects of Runx2 on bone development.

Authors:  Shiqin Zhang; Zhousheng Xiao; Junming Luo; Nan He; Josh Mahlios; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

2.  Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer.

Authors:  Omar Khalid; Sanjeev K Baniwal; Daniel J Purcell; Nathalie Leclerc; Yankel Gabet; Michael R Stallcup; Gerhard A Coetzee; Baruch Frenkel
Journal:  Endocrinology       Date:  2008-08-28       Impact factor: 4.736

3.  Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells.

Authors:  S K Baniwal; P K Shah; Y Shi; J H Haduong; Y A Declerck; Y Gabet; B Frenkel
Journal:  Osteoporos Int       Date:  2011-09-01       Impact factor: 4.507

4.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Authors:  Sanjeev K Baniwal; Omar Khalid; Yankel Gabet; Ruchir R Shah; Daniel J Purcell; Deepak Mav; Alice E Kohn-Gabet; Yunfan Shi; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

5.  Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus.

Authors:  John L Fowlkes; R Clay Bunn; Lichu Liu; Elizabeth C Wahl; Hannah N Coleman; Gael E Cockrell; Daniel S Perrien; Charles K Lumpkin; Kathryn M Thrailkill
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

6.  Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA.

Authors:  Sanjeev K Baniwal; Omar Khalid; Donna Sir; Grant Buchanan; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Endocrinol       Date:  2009-04-23

Review 7.  Representing ontogeny through ontology: a developmental biologist's guide to the gene ontology.

Authors:  David P Hill; Tanya Z Berardini; Douglas G Howe; Kimberly M Van Auken
Journal:  Mol Reprod Dev       Date:  2010-04       Impact factor: 2.609

8.  Polycomb PRC2 complex mediates epigenetic silencing of a critical osteogenic master regulator in the hippocampus.

Authors:  Rodrigo Aguilar; Fernando J Bustos; Mauricio Saez; Adriana Rojas; Miguel L Allende; Andre J van Wijnen; Brigitte van Zundert; Martin Montecino
Journal:  Biochim Biophys Acta       Date:  2016-05-20

9.  Novel regulators of Fgf23 expression and mineralization in Hyp bone.

Authors:  Shiguang Liu; Wen Tang; Jianwen Fang; Jinyu Ren; Hua Li; Zhousheng Xiao; L D Quarles
Journal:  Mol Endocrinol       Date:  2009-06-25

10.  Cyclooxygenase-2 inhibition does not impair block bone grafts healing in rabbit model.

Authors:  Eduardo Moreschi; Claudia Cristina Biguetti; Eliston Comparim; Leandro De Andrade Holgado; Paulo Domingos Ribeiro-Junior; Hugo Nary-Filho; Mariza Akemi Matsumoto
Journal:  J Mol Histol       Date:  2013-06-20       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.